Short Interest in Ascentage Pharma Group International (OTCMKTS:ASPHF) Expands By 392.3%

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the target of a significant increase in short interest in June. As of June 15th, there was short interest totaling 172,800 shares, an increase of 392.3% from the May 31st total of 35,100 shares. Based on an average daily volume of 51 shares, the days-to-cover ratio is presently 3,388.2 days.

Ascentage Pharma Group International Stock Performance

Shares of OTCMKTS ASPHF opened at $4.53 on Friday. Ascentage Pharma Group International has a twelve month low of $4.53 and a twelve month high of $5.05. The company has a 50 day moving average of $6.17 and a 200 day moving average of $7.67.

About Ascentage Pharma Group International

Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.

Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.